WALTHAM, Mass., Nov. 25, 2014 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) announced today that Mary Lynne Hedley, Ph.D., President and COO of TESARO, will present at the 2014 Deutsche Bank BioFEST Conference on Tuesday, December 2, 2014 at 4:00 p.m. ET in Boston.
A live webcast will be accessible via the Investors page of the TESARO website at www.tesarobio.com. An archived replay of this webcast will be available on the Company's website for 14 days after the conference.
TESARO, Inc. is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients.
CONTACT: For additional information, please contact: Jennifer Davis Sr. Director, Corporate Development & Investor Relations 1.781.325.1116 email@example.com